About IVY Pharma
IVY Pharma specializes in the development, licensing, acquisition and global distribution of therapeutic and aesthetic biopharmaceuticals. Our pipeline covers biosimilars and biomolecules for various chronic diseases and aesthetics.
Through strategic partnerships with leading pharmaceutical and biotechnology companies, we are building a portfolio of new biosimilar pipelines for further development and commercialization.
In addition, IVY Pharma has commercialized a line of medical aesthetic products containing botulinum toxin A, hyaluronic acid, skin boosters and peptide.
Our business strategy revolves around three key models:
- Unique and improved Biosimilars, Vaccines and Biopharmaceutical drugs for rare and chronic diseases
- Licensing and Partnership for Development and Commercialization
- Global Distribution
Distribution
IVY Pharma has established a global footprint spanning key markets across North America, South America, Southeast Asia, and the Middle East.
Our expanding global distribution network is driven by strategic partnerships with respected in-country partners who share our commitment to making biopharmaceuticals and biosimilars accessible to patients globally.
Business Development
IVY Pharma embraces a partnership-focused approach to business development that allows us to accelerate growth, mitigate risk, and maximize value across every stage of the biopharmaceutical lifecycle.
We actively build strategic alliances with industry leaders, top researchers, and innovators across the globe to expand our capabilities and pipeline. Our business development team has successfully negotiated partnerships in key areas: Early-Stage Research, Clinical Development, Licensing and Commercialization, and Manufacturing.
As we enter new markets and therapeutic spaces, fresh alliances offer avenues to access talent, infrastructure, funding, and intellectual property unavailable internally. Our growing global ecosystem of partners creates long-term, mutually beneficial relationships that ultimately benefit patients through reliable access to safe, pure, and effective biopharmaceuticals worldwide.